与obeticholic acid相关的不良事件:一个现实世界的药监测研究
1Department of Gastroenterology, Inner Mongolia Forestry General Hospital, Yakeshi, Inner Mongolia, China.
肥酸 (OCA) 是一种治疗初级胆道胆炎 (PBC) 的替代疗法. 这项研究发现和疲劳是常见的不良事件,严重的肝脏问题很少出现,强调在六个月内进行监测.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药物监督 药物监督 药物监督
- 自免疫性疾病 自免疫性疾病
背景情况:
- 初级胆道胆炎 (PBC) 是一种慢性自身免疫性肝脏疾病.
- Ursodeoxycholic 酸 (UDCA) 是主要的治疗方法,但许多患者表现出不充分的反应.
- 肥酸 (OCA) 是一种FXR激动剂,是一种具有有限长期安全数据的替代疗法.
研究的目的:
- 评估OCA在患有初级胆道胆炎 (PBC) 的患者中的安全性.
- 使用大规模的真实世界数据,识别与OCA相关的潜在不良事件信号.
主要方法:
- 使用了美国FDA不良事件报告系统 (FAERS) 数据库.
- 进行了大规模的数据挖掘和不成比例分析 (ROR,PRR,BCPNN,MGPS).
- 从2016年第二季度到2024年第一季度分析了5,864份与OCA相关的不良事件报告.
主要成果:
- 在27个系统器官类别中确定了显著的不良事件信号.
- 最常见的不良事件包括 (12.54%),疲劳 (4.16%) 和恶心 (1.64%).
- 严重的肝脏事件,如肝衰竭,很少发生 (0.6%);中位时间到发病是178天.
结论:
- OCA 显示出安全性,常见的不良事件包括和疲劳.
- 监测肝脏并发症至关重要,特别是在OCA治疗的最初六个月.
- 现实世界的数据挖掘为OCA在PBC管理中的安全提供了宝贵的见解.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
